Camellia (CAM) AI Stock Analysis

• Market Cap: £149.77M
• Dividend Yield: 4.39%
• Average Volume (3M): 280.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.42
• Revenue Growth: -0.79%
• EPS Growth: 87.50%
• Country: UK
• Employees: 79,254
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Agricultural Farm Products
• EPS (TTM): -4.29
• Shares Outstanding: 2,527,795
• 10 Day Avg. Volume: 370
• 30 Day Avg. Volume: 280
• PEG Ratio: 0.19
• Price to Book (P/B): 0.43
• Price to Sales (P/S): 0.50
• P/FCF Ratio: -10.85
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 55 Neutral
• Price Target: 5,689.00p ▼(-4.39% Downside)

Camellia's overall stock score reflects significant financial challenges, with persistent losses and liquidity issues overshadowing potential technical and strategic improvements. While the technical analysis suggests some short-term bullish momentum, and corporate actions like share buybacks and strategic plans are positive, the underlying financial weakness and valuation concerns weigh heavily on the score. The absence of earnings call data limits insights into management's outlook, further emphasizing the need for caution.

Camellia Business Overview & Revenue Model

Company Description

Camellia (CAM) is a diversified company engaged in various sectors including agriculture, healthcare, and real estate. The company primarily focuses on the cultivation and processing of tea and horticultural products, while also investing in healthcare services and property development. Its core products include premium tea varieties, wellness products, and residential and commercial real estate solutions.

How the Company Makes Money

Camellia generates revenue through multiple key streams. In the agricultural sector, the company profits from the sale of tea and horticultural products, leveraging its established brand and global distribution channels. The healthcare division contributes to revenue by providing specialized services and products, catering to a growing demand for health and wellness solutions. Additionally, Camellia earns income from its real estate investments, including rental income from properties and profits from property sales. The company has formed strategic partnerships with retailers and distributors, enhancing its market reach and driving sales. Seasonal trends and consumer preferences also significantly influence its earnings, as demand for premium tea and health-related products can fluctuate throughout the year.

Camellia Financial Statement Overview

Summary

Camellia's financial performance reflects substantial challenges. The income statement indicates ongoing profitability issues with declining revenues and persistent net losses. The balance sheet shows a solid equity position but signs of asset and equity erosion. Cash flow analysis reveals consistently negative cash flow from operations, indicating potential liquidity issues. While the company maintains adequate liquidity through cash reserves, the financial trajectory suggests a need for strategic adjustments to improve profitability and cash generation.

Income Statement

Camellia's income statement reveals a challenging landscape with declining revenues and negative net income over the last several years, indicating persistent losses. Although there was a minor improvement in EBIT and EBITDA margins in 2024, they remain relatively low. The gross profit margin has also decreased, reflecting cost pressures or pricing challenges. Overall, the income statement portrays a company struggling to maintain profitability and revenue growth.

Balance Sheet

The balance sheet shows a strong equity base with a favorable equity ratio, suggesting financial stability. However, the decreasing stockholders' equity and total assets indicate potential asset erosion. The debt-to-equity ratio remains low, which is positive, yet the decreasing assets and equity raise concerns about long-term sustainability. While the company maintains a good liquidity position due to high cash reserves, the trend of shrinking equity poses potential risks.

Cash Flow

Camellia's cash flow statement highlights significant challenges with consistently negative free cash flow and operating cash flow over recent years. This situation indicates difficulties in generating cash from operations and suggests reliance on external financing or asset sales to cover capital expenditures. The operating cash flow to net income ratio is poor, reflecting inefficiencies in cash conversion. Overall, the cash flow position suggests financial strain and potential liquidity risks.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	264.80M	262.20M	254.20M	297.20M	255.30M	291.20M
Gross Profit	48.40M	49.00M	48.90M	70.50M	57.50M	63.50M
EBITDA	8.10M	13.30M	30.40M	17.80M	17.70M	26.60M
Net Income	-3.10M	-4.90M	-3.70M	-13.60M	2.30M	-5.00M
Balance Sheet
Total Assets	441.20M	476.30M	499.70M	571.80M	593.50M	582.30M
Cash, Cash Equivalents and Short-Term Investments	100.90M	139.10M	48.90M	50.60M	65.80M	98.50M
Total Debt	32.90M	26.90M	33.20M	30.90M	32.50M	19.90M
Total Liabilities	128.80M	128.60M	136.40M	154.10M	156.20M	156.30M
Stockholders Equity	276.50M	308.50M	325.80M	365.00M	388.60M	376.60M
Cash Flow
Free Cash Flow	-16.00M	-12.10M	-26.50M	-20.30M	-22.70M	-900.00K
Operating Cash Flow	-5.60M	-2.60M	-14.90M	-5.90M	-12.00M	12.90M
Investing Cash Flow	30.50M	58.00M	10.00M	-3.20M	-4.00M	8.30M
Financing Cash Flow	-20.20M	-9.00M	-5.90M	-12.10M	-18.40M	-12.40M

Camellia Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5950.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CAM, the sentiment is Positive. The current price of 5950 is above the 20-day moving average (MA) of 5933.75, above the 50-day MA of 5883.50, and above the 200-day MA of 5144.11, indicating a neutral trend. The MACD of 16.26 indicates Positive momentum. The RSI at 50.30 is Neutral, neither overbought nor oversold. The STOCH value of 57.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CAM.

Camellia Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AEP	―	£545.07M	8.10	16.51%	1.99%	16.42%	33.07%
MPE	―	£705.46M	8.62	20.95%	2.88%	6.52%	59.56%
RE	―	£47.99M	4.40	10.87%	―	5.39%	―
Sector *	―	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
CAM	―	£149.77M	―	―	4.39%	-0.79%	87.50%
DKL	―	£5.71M	-1.13	-30.89%	―	-6.07%	50.59%

Camellia Corporate Events

Camellia Plc Announces Director Share Purchase

Camellia Plc has announced a transaction involving the purchase of its ordinary shares by Alec Hayley, a Non-Executive Director and person discharging managerial responsibility. This transaction, conducted on the London Stock Exchange, involved the acquisition of 172 shares at an aggregated price of £9,970. The announcement reflects the company’s adherence to UK Market Abuse Regulations and may indicate confidence in the company’s future performance.

The most recent analyst rating on (GB:CAM) stock is a Hold with a £5689.00 price target. To see the full list of analyst forecasts on Camellia stock, see the GB:CAM Stock Forecast page.

Camellia Plc Reports Stable First Half 2025 Results Amid Strategic Enhancements

Camellia Plc reported stable trading performance for the first half of 2025, with a focus on implementing its Value Enhancement Plan to improve business performance and shareholder returns. Despite challenges such as seasonal crop variations and geopolitical issues affecting demand, the company has strengthened its cash position through asset disposals and continued investments in diversification and operational efficiency. The company anticipates improved revenues and trading performance for the full year compared to 2024.

The most recent analyst rating on (GB:CAM) stock is a Hold with a £5689.00 price target. To see the full list of analyst forecasts on Camellia stock, see the GB:CAM Stock Forecast page.

Camellia Plc to Release Half Year Results on 5 September 2025

Camellia Plc announced it will release its Half Year Results for the period ending 30 June 2025 on 5 September 2025. The company will host a presentation for shareholders and potential investors to discuss the results, with an opportunity for live Q&A. This announcement highlights Camellia’s transparency and engagement with stakeholders, potentially impacting investor relations and market perception.

The most recent analyst rating on (GB:CAM) stock is a Hold with a £5689.00 price target. To see the full list of analyst forecasts on Camellia stock, see the GB:CAM Stock Forecast page.